Bon Natural Life Limited (BON) Fair Value & Analysis
Basic Materials · US · Market cap $12.4M
Bon Natural Life Limited
BON · US
Fair value as of: Jul 15, 2026
From 1 valuation models · updated today
Fair value updated Jul 15, 2026 — revised from $52.00 to $2.98 (−94.3%) since Jun 24, 2026. Share price −11.1% over the past month.
Price vs Fair Value (12 months)
12‑month range $1.13 – $2.28 · fair‑value band $1.97 – $3.72 · the $1.20 price screens below the $2.98 fair value. As of Jul 15, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Bon Natural Life Limited (BON) currently trades at $1.20, while our model-based Fair Value estimate is $2.98 — implying the stock looks roughly 148.3% undervalued today. We read business quality at 11/100 (below-average quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
Over the trailing twelve months, Bon Natural Life Limited generated revenue of $18.7M at a net margin of -10.7%. Revenue declined 21.9% year over year. It earns a return on equity of -4.0%. Net debt stands at $6.1M. Fundamentals as of Jul 15, 2026
Our scenario range runs from $1.97 (bear case) to $3.72 (bull case); at $1.20, the current price sits below that range. The share trades about 49% below its 52-week high and 6% above its 52-week low, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -69% fair-value upside — at 148%, BON screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 15, 2026. TTM = trailing twelve months.
About the company
Bon Natural Life Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China, Europe, North America, and the Middle East. The company offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements. It sells its products through direct distributors. The company serves manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company has a strategic partnership with Tigerbone Group Limited. Bon Natural Life Limited was founded in 2006 and is headquartered in Xi'an, the People's Republic of China.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Bon Natural Life Limited reported revenue of $18.7M in FY2025 versus $25.5M in FY2021, a compound −7.5%/yr. Reported net income was −$2.0M in FY2025.
Is BON fairly valued? → Check now
Similar stocks
10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 15, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | $509.16 | $159.69 | -69% |
| L'Air Liquide S.A AIQUY | $38.20 | $13.08 | -66% |
| Nan Ya Plastics Corporation 1303 | 154.50 TWD | 7.80 TWD | -95% |
| Intercontinental Exchange, Inc I1CE34 | R$367.00 | R$311.38 | -15% |
| Wanhua Chemical Group 600309 | ¥67.90 | ¥46.52 | -31% |
| Asian Paints Limited ASIANPAINT | ₹2,674 | ₹739.38 | -72% |
| PPG Industries, Inc P1PG34 | R$306.60 | R$38.89 | -87% |
| LyondellBasell Industries N.V L1YB34 | R$171.50 | R$190.25 | +11% |
| Solar Industries India Limited SOLARINDS | ₹17,697 | ₹2,793 | -84% |
| Pidilite Industries Limited PIDILITIND | ₹1,507 | ₹393.58 | -74% |
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Bon Natural Life Limited (BON) undervalued?
What is the fair value of BON?
What is the quality score of BON?
What is the revenue of Bon Natural Life Limited (BON)?
What is the net profit margin of BON?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Unlock the full Bon Natural Life Limited analysis — and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.